BVS Q3 2024 Earnings — Bioventus Inc. Revenue & Financial Results | Market Cap Arena

BVSBioventus Inc.

$593M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$139M+15.0% YoY

Gross Profit

$94M67.3% margin

Operating Income

$4M2.9% margin

Net Income

-$5M-3.5% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

-8.1%

Cash Flow

Operating Cash Flow

$10M

Free Cash Flow

$10M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$769M

Total Liabilities

$583M

Stockholders' Equity

$149M

Cash & Equivalents

$43M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$139M	$121M	+15.0%
Gross Profit	$94M	$79M	+18.6%
Operating Income	$4M	$2M	+68.5%
Net Income	-$5M	-$7M	+33.9%

Revenue Segments

U.S. Segment

$123M88%

International Segment

$16M12%

Geographic Segments

UNITED STATES

$123M88%

Non-US

$16M12%